Bispebjerg Hospital is one of the hospitals in the Capital Region of Denmark. Along with a number of other hospitals and the University of Copenhagen, Bispebjerg Hospital forms part of the Copenhagen University Hospital. The hospital is a teaching hospital for medical students from Copenhagen University.

During the past decade, Bispebjerg Hospital conducted 202 clinical trials. In the 10-year time frame, 202 clinical trials started and 31 clinical trials were completed, i.e. on average, 15.3% percent of trials that started reached the finish line to date. In the past 5 years, 106 clinical trials started and 22 clinical trials were completed. i.e. 20.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Bispebjerg Hospital" #1 sponsor was "Bispebjerg Hospital" with 102 trials, followed by "University Hospital Bispebjerg and Frederiksberg" with 16 trials sponsored, "Rigshospitalet, Denmark" with 14 trials sponsored, "Pfizer" with 8 trials sponsored and "Marius Henriksen" with 8 trials sponsored. Other sponsors include 159 different institutions and companies that sponsored additional 103 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Bispebjerg Hospital" #1 collaborator was "Bispebjerg Hospital" with 30 trials as a collaborator, "Rigshospitalet, Denmark" with 18 trials as a collaborator, "University of Copenhagen" with 17 trials as a collaborator, "Hvidovre University Hospital" with 14 trials as a collaborator and "Aarhus University Hospital" with 10 trials as a collaborator. Other collaborators include 268 different institutions and companies that were collaborators in the rest 179 trials.

According to Clinical.Site data, the most researched conditions in "Bispebjerg Hospital" are "Asthma" (12 trials), "Heart Failure" (7 trials), "Hernia, Ventral" (7 trials), "Atrial Fibrillation" (6 trials) and "Osteoarthrosis" (6 trials). Many other conditions were trialed in "Bispebjerg Hospital" in a lesser frequency.

Most popular intervention types in "Bispebjerg Hospital" are "Drug" (134 trials), "Other" (62 trials), "Device" (47 trials), "Procedure" (38 trials) and "Behavioral" (22 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (44 trials), "Dexamethasone" (6 trials), "Isotonic Sodium Chloride" (6 trials), "Methylprednisolone" (6 trials) and "Oxygen" (4 trials). Other intervention names were less common.

The vast majority of trials in "Bispebjerg Hospital" are 294 trials for "All" genders, 12 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are 71 active trials in "Bispebjerg Hospital". 6 are not yet recruiting, 50 are recruiting, 12 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 180 completed trials in Bispebjerg Hospital, undefined suspended trials, and 19 terminated clinical trials to date.

Out of the total trials that were conducted in Bispebjerg Hospital, 8 "Phase 1" clinical trials were conducted, 40 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 41 trials, and there were also 123 trials that are defined as “Not Applicable".

Bispebjerg Hospital has several departments that took part in Clinical trials: "Department of Dermatology, Bispebjerg Hospital" - 7 trials, "Cardiology department Y, Bispebjerg-Frederiksberg Hospital" - 2 trials, "Videncenter for Sårheling Bispebjerg Hospital" - 2 trials